Metraipolis › archive › dc_8e37f548cd3f
Causal Analysis of Health Interventions and Environments for Influencing the Spread of COVID-19 in the United States of America — Europe PMC PPR:PPR220271
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR220271
- DOI
- 10.1101/2020.09.29.20203505
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T10:06:45.263Z
- SHA-256 of the archived text
9c6a6a735ddd432dd63d5a0a169e4ac19f16a4d060614d36fc3bacdf6b4dc049- Stable URL of this page
https://metraipolis.com/documento/dc_8e37f548cd3f
How to cite
Causal Analysis of Health Interventions and Environments for Influencing the Spread of COVID-19 in the United States of America — Europe PMC PPR:PPR220271 — Europe PMC, https://europepmc.org/article/PPR/PPR220271 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_8e37f548cd3f (Metraipolis archive dc_8e37f548cd3f, sha256 9c6a6a735ddd432dd63d5a0a169e4ac19f16a4d060614d36fc3bacdf6b4dc049)
BibTeX
@misc{dc8e37f548cd3f,
title = {Causal Analysis of Health Interventions and Environments for Influencing the Spread of COVID-19 in the United States of America — Europe PMC PPR:PPR220271},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR220271},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_8e37f548cd3f; sha256 9c6a6a735ddd432dd63d5a0a169e4ac19f16a4d060614d36fc3bacdf6b4dc049},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR220271. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
As of August 27, 2020, the number of cumulative cases of COVID-19 in the US exceeded 5,863,363 and included 180,595 deaths, thus causing a serious public health crisis. Curbing the spread of Covid-19 is still urgently needed. Given the lack of potential vaccines and effective medications, non-pharmaceutical interventions are the major option to curtail the spread of COVID-19. An accurate estimate of the potential impact of different non-pharmaceutical measures on containing, and identify risk factors influencing the spread of COVID-19 is crucial for planning the most effective interventions to curb the spread of COVID-19 and to reduce the deaths. Additive model-based bivariate causal discovery for scalar factors and multivariate Granger causality tests for time series factors are applied to the surveillance data of lab-confirmed Covid-19 cases in the US, University of Maryland Data (UMD) data, and Google mobility data from March 5, 2020 to August 25, 2020 in order to evaluate the contributions of social-biological factors, economics, the Google mobility indexes, and the rate of the virus test to the number of the new cases and number of deaths from COVID-19. We found that active cases/1000 people, workplaces, tests done/1000 people, imported COVID-19 cases, unemployment rate and unemployment claims/1000 people, mobility trends for places of residence (residential), retail and test capacity were the most significant risk factor for the new cases of COVID-19 in 23, 7, 6, 5, 4, 2, 1 and 1 states, respectively, and that active cases/1000 people, workplaces, residential, unemployment rate, imported COVID cases, unemployment claims/1000 people, transit stations, mobility trends (transit), tests done/1000 people, grocery, testing capacity, retail, percentage of change in consumption, percentage of working from home were the most significant risk factor for the deaths of COVID-19 in 17, 10, 4, 4, 3, 2, 2, 2, 1, 1, 1, 1 states, respectively. We observed that no metrics showed significant evidence in mitigating the COVID-19 epidemic in FL and only a few metrics showed evidence in reducing the number of new cases of COVID-19 in AZ, NY and TX. Our results showed that the majority of non-pharmaceutical interventions had a large effect on slowing the transmission and reducing deaths, and that health interventions were still needed to contain COVID-19. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2020 (prima pubblicazione 2020-09-29). Identificativi: DOI 10.1101/2020.09.29.20203505. Pagina: https://europepmc.org/article/PPR/PPR220271 — https://doi.org/10.1101/2020.09.29.20203505. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T10:02:22.055Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.